Abstract

We previously found that retinoblastoma (RB) is cleaved at the initiation of apoptotic execution. Here we report that when an HL‐60 cell line resistant to cytosine arabinoside (Ara‐C) was exposed to this anticancer drug, neither RB cleavage nor apoptosis was detected. Consistent with that, processing of interleukin 1β‐converting enzyme (ICE) and CPP32 (an ICE‐like protease) was also prevented in these cells. In contrast, treatment of the HL‐60‐Ara‐C‐resistant cells with etoposide induced all of these apoptotic events. Furthermore, the etoposide‐induced RB cleavage was inhibited by a specific tetrapeptide ICE‐like inhibitor. Our results demonstrate that activation of the RB cleavage enzyme, an ICE‐like protease, is required for overcoming drug resistance.

Keywords

ProteasesEtoposideCleavage (geology)ProteaseChemistryApoptosisEnzymeCaspaseTetrapeptideRetinoblastomaMolecular biologyBiochemistryCell biologyBiologyProgrammed cell deathPeptide

Affiliated Institutions

Related Publications

Publication Info

Year
1996
Type
article
Volume
399
Issue
1-2
Pages
158-162
Citations
21
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

21
OpenAlex

Cite This

Bing An, Jiarui Jin, Peggy M. Lin et al. (1996). Failure to activate interleukin 1β‐converting enzyme‐like proteases and to cleave retinoblastoma protein in drug‐resistant cells. FEBS Letters , 399 (1-2) , 158-162. https://doi.org/10.1016/s0014-5793(96)01311-7

Identifiers

DOI
10.1016/s0014-5793(96)01311-7